NC
RCEL icon

nVerses Capital’s Avita Medical RCEL Stock Holding History

nVerses Capital’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.4K Buy
+13,668
New +$59K 0.09% 271
2024
Q4 		– Sell
-900
Closed -$9.65K – 688
2024
Q3 		$9.65K Buy
+900
New +$8.45K ﹤0.01% 897

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

nVerses Capital's RCEL Position: Q2 2026 in Review

nVerses Capital opened a new position in Avita Medical (RCEL) in Q2 2026: 13,668 shares worth $56.4K. The stake represents 0.09% of the portfolio and ranks #271 among its holdings. This is a return to the name: nVerses Capital previously reported a position in RCEL as recently as Q3 2024.

nVerses Capital first reported a position in RCEL in Q3 2024 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • nVerses Capital held 13,668 shares of Avita Medical worth $56.4K as of Q2 2026.
  • Avita Medical was a new nVerses Capital position in Q2 2026.
  • Avita Medical made up 0.09% of nVerses Capital's portfolio in Q2 2026, its #271 holding.
  • nVerses Capital first reported a position in Avita Medical in Q3 2024 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.